Compare CVKD & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVKD | ARTW |
|---|---|---|
| Founded | 2022 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7M | 11.9M |
| IPO Year | 2023 | N/A |
| Metric | CVKD | ARTW |
|---|---|---|
| Price | $7.95 | $2.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | ★ 64.9K | 27.8K |
| Earning Date | 11-10-2025 | 10-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $24,079,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.58 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.43 | $1.43 |
| 52 Week High | $22.90 | $4.71 |
| Indicator | CVKD | ARTW |
|---|---|---|
| Relative Strength Index (RSI) | 36.68 | 42.12 |
| Support Level | $7.43 | $2.18 |
| Resistance Level | $12.50 | $2.55 |
| Average True Range (ATR) | 1.05 | 0.14 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 10.31 | 8.11 |
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.